Trupanion (NASDAQ:TRUP) is scheduled to be issuing its quarterly earnings data after the market closes on Thursday, November 8th. Analysts expect the company to announce earnings of ($0.01) per share for the quarter.
Trupanion (NASDAQ:TRUP) last released its quarterly earnings results on Thursday, August 2nd. The financial services provider reported ($0.01) EPS for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.05) by $0.04. Trupanion had a negative net margin of 0.84% and a negative return on equity of 4.43%. The firm had revenue of $73.39 million for the quarter, compared to analyst estimates of $72.70 million. During the same quarter in the previous year, the company earned ($0.02) EPS. The business’s revenue for the quarter was up 25.9% compared to the same quarter last year. On average, analysts expect Trupanion to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.
Trupanion stock opened at $25.26 on Thursday. Trupanion has a fifty-two week low of $24.37 and a fifty-two week high of $46.70. The company has a debt-to-equity ratio of 0.16, a current ratio of 3.04 and a quick ratio of 3.04. The company has a market capitalization of $847.74 million, a P/E ratio of -360.86 and a beta of 0.60.
In other Trupanion news, Director Murray B. Low sold 3,000 shares of the business’s stock in a transaction on Friday, August 10th. The shares were sold at an average price of $38.12, for a total value of $114,360.00. Following the completion of the transaction, the director now owns 189,782 shares in the company, valued at $7,234,489.84. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, insider Darryl Rawlings sold 4,000 shares of the business’s stock in a transaction on Friday, October 12th. The stock was sold at an average price of $29.04, for a total transaction of $116,160.00. Following the completion of the transaction, the insider now owns 1,277,989 shares of the company’s stock, valued at approximately $37,112,800.56. The disclosure for this sale can be found here. In the last 90 days, insiders sold 23,300 shares of company stock valued at $829,046. Insiders own 20.70% of the company’s stock.
An institutional investor recently raised its position in Trupanion stock. Bank of New York Mellon Corp grew its holdings in Trupanion Inc (NASDAQ:TRUP) by 3.7% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 84,145 shares of the financial services provider’s stock after acquiring an additional 2,967 shares during the period. Bank of New York Mellon Corp owned about 0.26% of Trupanion worth $3,248,000 as of its most recent filing with the Securities & Exchange Commission. Hedge funds and other institutional investors own 93.37% of the company’s stock.
Trupanion Company Profile
Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on monthly subscription basis in the United States, Canada, and Puerto Rico. The company operates through Subscription Business and Other Business segments. It serves pet owners and veterinarians through third-party referrals and online member acquisition channels.
Featured Article: How to Invest in the Dividend Aristocrat Index
Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.